NASDAQ:NEOG

Neogen (NEOG) Stock Price, News & Analysis

$12.31
+0.53 (+4.50%)
(As of 04/23/2024 ET)
Today's Range
$11.77
$12.41
50-Day Range
$11.61
$17.64
52-Week Range
$11.46
$24.09
Volume
2.66 million shs
Average Volume
2.67 million shs
Market Capitalization
$2.67 billion
P/E Ratio
1,232.23
Dividend Yield
N/A
Price Target
$22.50

Neogen MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.50 Rating Score
Upside/​Downside
82.8% Upside
$22.50 Price Target
Short Interest
Bearish
7.71% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.59mentions of Neogen in the last 14 days
Based on 8 Articles This Week
Insider Trading
Acquiring Shares
$662,205 Bought Last Quarter
Proj. Earnings Growth
28.00%
From $0.50 to $0.64 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

3.49 out of 5 stars

Medical Sector

292nd out of 909 stocks

Diagnostic Substances Industry

5th out of 11 stocks

NEOG stock logo

About Neogen Stock (NASDAQ:NEOG)

Neogen Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells, as well as provides genomics-based diagnostic technology and software systems that help testers to objectively analyze and store their results and perform analysis on the results from multiple locations over extended periods. The segment offers its products primarily to milling and grain, meat and poultry, prepared foods and ingredients, fruits and vegetables, seafood, dairy, beverage, water, healthcare, traditional culture media markets, food service, and dietary supplements markets. The Animal Safety segment provides veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products, and genomics testing services marketed through veterinarians, retailers, livestock producers, and animal health product distributors, for the animal safety market. The segment offers its products for companion animal veterinarians; livestock producers, veterinarians, and breed associations; retailers; breeding and genetics companies; diagnostic labs and universities; distributors; and other manufacturers and government agencies. Neogen Corporation was incorporated in 1981 and is headquartered in Lansing, Michigan.

NEOG Stock Price History

NEOG Stock News Headlines

$25,000 into $109,616 in two months?
Today I want to show you how our research shows you could’ve grown a $25,000 account into $109,616.12 within the last TWO months. You see, former multi-million dollar hedge fund manager Roger Scott spent the better half of 2023 developing what might be the most advanced trading tool that exists… It’s a revolutionary software system that tracks the moves of institutional investors…. in real time…
Neogen Co. (NASDAQ:NEOG) CFO Buys $156,375.00 in Stock
Neogen (NASDAQ:NEOG) Reaches New 12-Month Low at $11.46
$25,000 into $109,616 in two months?
Today I want to show you how our research shows you could’ve grown a $25,000 account into $109,616.12 within the last TWO months. You see, former multi-million dollar hedge fund manager Roger Scott spent the better half of 2023 developing what might be the most advanced trading tool that exists… It’s a revolutionary software system that tracks the moves of institutional investors…. in real time…
Neogen (NASDAQ:NEOG) Hits New 52-Week Low on Analyst Downgrade
Neogen Sinks 16% In Pre-market On Lowered Annual Outlook
Q3 2024 Neogen Corp Earnings Call
See More Headlines
Receive NEOG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Neogen and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
4/09/2024
Today
4/24/2024
Fiscal Year End
5/31/2024
Next Earnings (Estimated)
7/25/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Diagnostic substances
Sub-Industry
Health Care Supplies
Current Symbol
NASDAQ:NEOG
CUSIP
64049110
Employees
2,640
Year Founded
1982

Price Target and Rating

Average Stock Price Target
$22.50
High Stock Price Target
$28.00
Low Stock Price Target
$17.00
Potential Upside/Downside
+82.8%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
2 Analysts

Profitability

Net Income
$-22,870,000.00
Pretax Margin
-0.03%

Debt

Sales & Book Value

Annual Sales
$822.45 million
Cash Flow
$0.96 per share
Book Value
$14.49 per share

Miscellaneous

Free Float
215,070,000
Market Cap
$2.67 billion
Optionable
Optionable
Beta
1.13

Social Links

Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

NEOG Stock Analysis - Frequently Asked Questions

Should I buy or sell Neogen stock right now?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Neogen in the last twelve months. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" NEOG shares.
View NEOG analyst ratings
or view top-rated stocks.

What is Neogen's stock price target for 2024?

2 Wall Street research analysts have issued 12 month price objectives for Neogen's stock. Their NEOG share price targets range from $17.00 to $28.00. On average, they expect the company's stock price to reach $22.50 in the next twelve months. This suggests a possible upside of 82.8% from the stock's current price.
View analysts price targets for NEOG
or view top-rated stocks among Wall Street analysts.

How have NEOG shares performed in 2024?

Neogen's stock was trading at $20.11 at the beginning of the year. Since then, NEOG shares have decreased by 38.8% and is now trading at $12.31.
View the best growth stocks for 2024 here
.

When is Neogen's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, July 25th 2024.
View our NEOG earnings forecast
.

How were Neogen's earnings last quarter?

Neogen Co. (NASDAQ:NEOG) issued its quarterly earnings results on Tuesday, April, 9th. The company reported $0.12 earnings per share for the quarter, missing analysts' consensus estimates of $0.14 by $0.02. The business earned $228.80 million during the quarter, compared to the consensus estimate of $230.01 million. Neogen had a trailing twelve-month return on equity of 3.35% and a net margin of 0.17%. The firm's revenue for the quarter was up 4.8% on a year-over-year basis. During the same period in the prior year, the business earned $0.12 earnings per share.

What ETFs hold Neogen's stock?
When did Neogen's stock split?

Shares of Neogen split before market open on Tuesday, January 2nd 2018. The 4-3 split was announced on Friday, December 8th 2017. The newly issued shares were payable to shareholders after the closing bell on Friday, December 29th 2017. An investor that had 100 shares of stock prior to the split would have 133 shares after the split.

What guidance has Neogen issued on next quarter's earnings?

Neogen issued an update on its FY 2024 earnings guidance on Tuesday, April, 9th. The company provided EPS guidance of for the period. The company issued revenue guidance of $910.0 million-$920.0 million, compared to the consensus revenue estimate of $938.2 million.

What is John Adent's approval rating as Neogen's CEO?

31 employees have rated Neogen Chief Executive Officer John Adent on Glassdoor.com. John Adent has an approval rating of 56% among the company's employees. This puts John Adent in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Neogen own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Neogen investors own include NVIDIA (NVDA), NIKE (NKE), Pfizer (PFE), AT&T (T), AbbVie (ABBV), Boeing (BA), JPMorgan Chase & Co. (JPM), W. P. Carey (WPC), Advanced Micro Devices (AMD) and Costco Wholesale (COST).

Who are Neogen's major shareholders?

Neogen's stock is owned by a number of institutional and retail investors. Top institutional investors include AMI Asset Management Corp (0.13%), Bridge City Capital LLC (0.08%), Amalgamated Bank (0.05%), Sumitomo Mitsui Trust Holdings Inc. (0.04%), Northwest Investment Counselors LLC (0.03%) and Wesbanco Bank Inc. (0.03%). Insiders that own company stock include Darci L Vetter, David H Naemura, Douglas Edward Jones, James C Borel, James P Tobin, Jason Warren Lilly, John Edward Adent, Ronald D Green, Steven J Quinlan, Terri A Morrical and William T Boehm.
View institutional ownership trends
.

How do I buy shares of Neogen?

Shares of NEOG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:NEOG) was last updated on 4/24/2024 by MarketBeat.com Staff

From Our Partners